New vaccines are often evaluated in trials in which some participants receive a placebo. But not all studies can be designed ...

The real-world data showed lower rates of atrial fibrillation and hypertension associated with the second-generation Bruton ...

Omeros Corporation (NASDAQ: OMER) Q1 2025 Earnings Call Transcript May 15, 2025 Omeros Corporation misses on earnings ...

Operator: Greetings and welcome to the BiomX First Quarter 2025 Financial Results Conference Call. At this time, all ...

Immune checkpoint inhibitors, such as Opdivo (nivolumab) and Keytruda (pembrolizumab), have been a huge advance in the ...

Sumitomo Pharma Co. shares surged by the most since 1992 after results of a study showed the safety and potential benefits of stem cells used to treat Parkinson’s disease. The stock jumped 20 percent, ...

Cities such as Guangzhou and San Francisco already have robotaxis and autonomous buses for public use, but Singapore is ...

For patients with EGFR-mutated NSCLC, treatment options in the frontline include osimertinib monotherapy, amivantamab with ...

After decades of hype and setbacks, scientists have made impressive progress into tricking stem cells into repairing organs.

Novo Nordisk CEO's ouster signals stiff competition in the obesity market, getting dominated by Eli Lilly, with Roche, ...

An infant with a rare urea cycle disorder became the first patient to receive a personalized gene-editing therapy. His care ...

A three-judge D.C. Circuit panel expressed concern that ruling in the government's favor could strip over 30 federal agencies of their independence.